Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001599901-25-000005
Filing Date
2025-01-08
Accepted
2025-01-08 18:42:50
Documents
4
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1736379763.html 3  
1 FORM 3 wk-form3_1736379763.xml 3 1700
2 EX-24.1 avidity-powerofattorneys.htm EX-24.1 6016
3 avidity-powerofattorneys001.jpg GRAPHIC 266757
4 avidity-powerofattorneys002.jpg GRAPHIC 96974
  Complete submission text file 0001599901-25-000005.txt   510562
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Issuer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10578 SCIENCE CENTER DRIVE, SUITE 125 SAN DIEGO CA 92121
Business Address
Calderaro Charles III (Reporting) CIK: 0002049888 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39321 | Film No.: 25519625